Standard
High facility preference for rivaroxaban in atrial fibrillation increases risk of major bleeding compared to facility preference for apixaban. / Bonde, A. N.; Martinussen, T.; Lee, C. Y.; Bhattacharya, J.; Lip, G. Y. H.; Staerk, L.; Gislason, G.; Torp-Pedersen, C.; Olesen, J. B.; Hlatky, M.
In:
European Heart Journal, Vol. 40, No. Supplement 1, P4779, 2019, p. 2983.
Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
Harvard
Bonde, AN
, Martinussen, T, Lee, CY, Bhattacharya, J, Lip, GYH, Staerk, L
, Gislason, G, Torp-Pedersen, C, Olesen, JB & Hlatky, M 2019, '
High facility preference for rivaroxaban in atrial fibrillation increases risk of major bleeding compared to facility preference for apixaban',
European Heart Journal, vol. 40, no. Supplement 1, P4779, pp. 2983.
https://doi.org/10.1093/eurheartj/ehz745.1155APA
Bonde, A. N.
, Martinussen, T., Lee, C. Y., Bhattacharya, J., Lip, G. Y. H., Staerk, L.
, Gislason, G., Torp-Pedersen, C., Olesen, J. B., & Hlatky, M. (2019).
High facility preference for rivaroxaban in atrial fibrillation increases risk of major bleeding compared to facility preference for apixaban.
European Heart Journal,
40(Supplement 1), 2983. [P4779].
https://doi.org/10.1093/eurheartj/ehz745.1155Vancouver
Bonde AN
, Martinussen T, Lee CY, Bhattacharya J, Lip GYH, Staerk L et al.
High facility preference for rivaroxaban in atrial fibrillation increases risk of major bleeding compared to facility preference for apixaban.
European Heart Journal. 2019;40(Supplement 1):2983. P4779.
https://doi.org/10.1093/eurheartj/ehz745.1155Author
Bonde, A. N. ; Martinussen, T. ; Lee, C. Y. ; Bhattacharya, J. ; Lip, G. Y. H. ; Staerk, L. ; Gislason, G. ; Torp-Pedersen, C. ; Olesen, J. B. ; Hlatky, M. / High facility preference for rivaroxaban in atrial fibrillation increases risk of major bleeding compared to facility preference for apixaban. In: European Heart Journal. 2019 ; Vol. 40, No. Supplement 1. pp. 2983.
Bibtex
@article{43c55d6313d6480f8573fbe6d711a614,
title = "High facility preference for rivaroxaban in atrial fibrillation increases risk of major bleeding compared to facility preference for apixaban",
author = "Bonde, {A. N.} and T. Martinussen and Lee, {C. Y.} and J. Bhattacharya and Lip, {G. Y. H.} and L. Staerk and G. Gislason and C. Torp-Pedersen and Olesen, {J. B.} and M. Hlatky",
year = "2019",
doi = "10.1093/eurheartj/ehz745.1155",
language = "English",
volume = "40",
pages = "2983",
journal = "European Heart Journal",
issn = "0195-668X",
publisher = "Oxford University Press",
number = "Supplement 1",
}
RIS
TY - ABST
T1 - High facility preference for rivaroxaban in atrial fibrillation increases risk of major bleeding compared to facility preference for apixaban
AU - Bonde, A. N.
AU - Martinussen, T.
AU - Lee, C. Y.
AU - Bhattacharya, J.
AU - Lip, G. Y. H.
AU - Staerk, L.
AU - Gislason, G.
AU - Torp-Pedersen, C.
AU - Olesen, J. B.
AU - Hlatky, M.
PY - 2019
Y1 - 2019
U2 - 10.1093/eurheartj/ehz745.1155
DO - 10.1093/eurheartj/ehz745.1155
M3 - Conference abstract in journal
VL - 40
SP - 2983
JO - European Heart Journal
JF - European Heart Journal
SN - 0195-668X
IS - Supplement 1
M1 - P4779
ER -
